About Cytosolix
Cytosolix is a private company based in Tolland, Connecticut. It has reported $6,605,171 raised in one offering on Form D since June 2023. Its chief executive is Colin Foster.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 12, 2023 | Jun 28, 2023 | $6,605,171fully sold | 12 | $550K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Cytosolix's Form D filed Jun 28, 2023.
JW
Jason Whitmire
Director
JD
John Deacon
Executive officer and director
CF
Colin Foster
Chief Executive Officer and director
Also a director at Ascendia Pharmaceutical Solutions and OncoSynergy and a board member at NBO Pharma.
AB
Alex Brunicki
Director